发明名称 THIENOPYRIMIDINE COMPOUNDS
摘要 <p>This invention provides thienopyrimidine compounds of the formula, (I) wherein R1 stands for hydrogen atom, an alkyl group or the like, and R1 is attached to either A1 or A2; R2 stands for a hydrogen atom, an alkyl or amino group or the like, R3 stands for an alkyl, alkenyl or alkylthio group or the like or a group Y-X-; or R2 and R3 may together form tetramethylene group; R4 stands for carboxylic acid, alkylsulfonylaminocarbonyl group or the like; X standing for a direct bond or linking group such as CH2, CH(OH), S, O, NH; Y standing for a substituted or unsubstituted aromatic carbocycylic, aromatic heterocylic, cycloalkyl or saturated heterocyclic group or the like; Z stands for S or O, and n is O or an integer of 1 to 4; one of A1 and A2 stands for carbon atom and the other stands for sulfur atom, or salts thereof, which exhibit an inhibitory effect on PDE9, and are therefore useful for prevention or treatment of overactive bladder syndrome, pollakiuria, urinary incontinence, dysuria associated with prostatic hyperplasia, urolithiasis, Alzheimer's disease, chronic obstructive pulmonary disease, myocardial infarction, thrombosis, diabetes and the like.</p>
申请公布号 WO2012004900(A1) 申请公布日期 2012.01.12
申请号 WO2010JP62022 申请日期 2010.07.09
申请人 ASKA PHARMACEUTICAL CO., LTD.;OKADA MAKOTO;SATO SHUICHIRO;KAWADE KENJI 发明人 OKADA MAKOTO;SATO SHUICHIRO;KAWADE KENJI
分类号 C07D495/04;A61K31/519;A61P3/10;A61P7/02;A61P9/10;A61P9/12;A61P11/00;A61P13/02;A61P13/04;A61P13/08;A61P13/10;A61P15/10;A61P25/28;A61P43/00 主分类号 C07D495/04
代理机构 代理人
主权项
地址